Compare ImmunityBio Inc. Common Stock (IBRX) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Payoneer Global Inc — how do they compare? ImmunityBio Inc. Common Stock trades at $10.72 (market cap $10.51B), while Payoneer Global Inc trades at $7.15 (market cap $2.43B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 4.3× Payoneer Global Inc's market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 1,342,701). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Payoneer Global Inc for 61 Days on average.
| IBRX | PAYO | |
|---|---|---|
Market Cap | $10.51B | $2.43B |
Volume | 10,445,785 | 1,342,701 |
Sector | Health | Technology |
52-Week High | $11.55 | $7.18 |
52-Week Low | $1.98 | $4.27 |
Typical Hold Time | 1 Days | 61 Days |
Enterprise Value | $10.97B | $2.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Payoneer Global (PAYO) trades at $7.15, down slightly by 0.14% with a bullish technical signal from moving averages. The company reported Q2 2026 earnings of $0.02 per share, missing estimates, but revenue grew 10% excluding interest. Recent news highlights Payoneer's renewed partnership with Etsy through 2029 and the company's agreement to be acquired by Nuvei announced in June 2026. Analyst sentiment remains positive with 60% buy ratings despite recent earnings volatility.
The acquisition by Nuvei creates near-term upside potential, but execution risks and margin compression pose challenges. Revenue growth remains solid at 15% volume growth year-over-year, though net income margin has declined from 16.8% in 2024 to 5.8% projected for 2026. The stock's valuation at 51x P/E appears stretched relative to earnings growth, suggesting cautious optimism is warranted.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
